Acuity Surgical Devices, LLC has received regulatory clearance from the FDA through a special 510(k) application for their additively manufactured spinal interbody device portfolio with HAnano Surface, expanding the variety...
ST. LOUIS, Oct. 13, 2022 /PRNewswire/ -- ulrich medical USA, Inc., a privately held medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today announced the FDA has...
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that the Virtuos™ Lyograft has received the 2022 Spine Technology Award from Orthopedics...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced expanded rollout of its augmented reality (AR) surgical navigation solution - ClarifEye - to Japan, highlighting positive...
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the full market release and first implants of Legacy Demineralized Bone...
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced that at the 2022 NASS Annual Meeting, the Company will...
WESTMINSTER, Colo., Oct. 11, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launch of the...
CTL Amedica Corporation has received official 510k clearance from the U.S. Food and Drug Administration (FDA) to market its MONDRIAN Anterior Lumbar Interbody Fusion (ALIF) Cage System with Supplementary Fixation...
PALM BEACH GARDENS, Fla., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard...
CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed® announced today that the first patients have been enrolled in the COMPaSS™ study. COMPaSS, Clinical Outcome Measures in Personalized aprevo® Spine Surgery, is a multi-center post market prospective observational registry. The study will collect data...